Karen O’Hanlon Cohrt - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Karen O’Hanlon Cohrt's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Karen O’Hanlon Cohrt

Karen O’Hanlon Cohrt

Verified

Editor-in-Chief, CRISPR Medicine News

Ireland

Final Covers

Pets, Mental Health , Nutrition, Health , Profiles, Fitness

Doesn’t Cover

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 166

  • Korro Bio to Begin RNA-Editing Trial in Alpha-1 Antitrypsin Deficiency

    By Karen O’Hanlon Cohrt

    Dec. 04, 2024

  • Sound-Guided CRISPR: Ultrasound Unlocks Precision Gene Editing

    By Karen O’Hanlon Cohrt

    Dec. 03, 2024

  • Korro Bio to Begin RNA-Editing Trial in Alpha-1 Antitrypsin Deficiency

    By Karen O’Hanlon Cohrt

    Dec. 04, 2024

As seen in

Company Info

CRISPR Medicine News

CRISPR Medicine News (CMN) is a media platform dedicated to the field of genetic medicine, gene therapy, and CRISPR-based genome editing technologies. It serves as an information hub, providing in-depth interviews, news, and analyses to keep stakeholders updated on advancements in CRISPR therapeutics. CMN focuses on news reporting, expert interviews, and educational content related to CRISPR technology. It covers topics such as clinical trial progress, regulatory developments, and industry best practices. The platform targets a professional audience, including researchers, biotech and pharmaceutical professionals, regulatory experts, and healthcare providers, all of whom are engaged in the evolving landscape of CRISPR therapies.

, ,

Founded: 2019